The Latest

New YorkNew York
NEW: How New York’s ‘Essential Plan’ insurance coverage cuts are forcing impossible choices

NEW: How New York’s ‘Essential Plan’ insurance coverage cuts are forcing impossible choices

Thousands of New Yorkers face tough decisions over health insurance as "Essential Plan" coverage for some comes to an end. Here’s a look at how one Brooklyn resident is weighing her options.

Trenton Daniel, Healthbeat New York
Trenton Daniel, Healthbeat New York
AtlantaAtlanta
What I learned on the Atlanta public health beat

What I learned on the Atlanta public health beat

Thank you for sharing your challenges and triumphs over the past two years.

Rebecca Grapevine, Healthbeat
Rebecca Grapevine, Healthbeat
AtlantaAtlanta
Sharing an update on Healthbeat Atlanta

Sharing an update on Healthbeat Atlanta

Thank you for reading and supporting Healthbeat Atlanta over the past two years.

Elizabeth Green, CEO, Civic News Company
Elizabeth Green, CEO, Civic News Company
GlobalGlobal
Why the hantavirus cruise is getting so much attention — and how much to worry

Why the hantavirus cruise is getting so much attention — and how much to worry

It has all the ingredients of a thriller movie and brings back memories of the beginnings of Covid. But the risk to the global population is low.

William Herkewitz, Healthbeat
William Herkewitz, Healthbeat
NationalNational
It’s a dangerous time for mothers and babies in the U.S.

It’s a dangerous time for mothers and babies in the U.S.

Access to essential medications is at risk. Babies are dying because parents are refusing the vitamin K shot. And homicide and suicide are now the leading causes of death in pregnant women.

Dr. Jay K. Varma, Healthbeat
Dr. Jay K. Varma, Healthbeat
GlobalGlobal
Why it’s so hard to get better drugs for neglected diseases

Why it’s so hard to get better drugs for neglected diseases

There’s little financial incentive for pharmaceutical companies to invest in a medicine whose target market is the very poorest people in the world.

William Herkewitz, Healthbeat
William Herkewitz, Healthbeat
NationalNational
Tick bites are rising: What to know about Lyme disease and alpha-gal syndrome

Tick bites are rising: What to know about Lyme disease and alpha-gal syndrome

The lone star tick is driving the rapid rise of alpha-gal syndrome, a delayed allergy to red meat, and cases may be undercounted. Meanwhile, a new vaccine for Lyme disease faces challenges.

Dr. Jay K. Varma, Healthbeat
Dr. Jay K. Varma, Healthbeat
AtlantaAtlanta
A message for Georgia’s public health workers: ‘Resist anticipatory obedience’

A message for Georgia’s public health workers: ‘Resist anticipatory obedience’

At a virtual statewide meeting, keynote speaker Nandi Marshall delivered a pointed message: Trust communities as experts, rethink your work, and don’t preemptively bend to politics.

Rebecca Grapevine, Healthbeat
Rebecca Grapevine, Healthbeat
GlobalGlobal
A new discovery could help end disfigurement of ‘very poorest children’

A new discovery could help end disfigurement of ‘very poorest children’

Noma ‘is the quintessential neglected disease,’ striking mostly children under 6 in several African countries. There has been very little research on it.

William Herkewitz, Healthbeat
William Herkewitz, Healthbeat
NationalNational
Psychedelics offer exciting promise for mental health — if rolled out right

Psychedelics offer exciting promise for mental health — if rolled out right

While there is substantial real-world data on the safety of most psychedelics, we need high-quality research to demonstrate the effectiveness of different dosages and treatment protocols.

Dr. Jay K. Varma, Healthbeat
Dr. Jay K. Varma, Healthbeat
AtlantaAtlanta
⚽ Atlanta’s public health goals for FIFA World Cup

⚽ Atlanta’s public health goals for FIFA World Cup

Preparations for this summer’s influx of soccer fans include food safety and outbreak prevention.

Rebecca Grapevine, Healthbeat
Rebecca Grapevine, Healthbeat
GlobalGlobal
New data on PEPFAR show fewer people tested (and preventively treated) for HIV

New data on PEPFAR show fewer people tested (and preventively treated) for HIV

Funding for the U.S. aid program has dropped about 30%. As one expert said, "We're building up problems for the future."

William Herkewitz, Healthbeat
William Herkewitz, Healthbeat
FirstBack
12345678
Next Last